When antipsychotic medications fail to stop auditory hallucinations—the distressing perception of voices without any external sound—researchers are turning to brain stimulation techniques that directly target the neural circuits responsible for these symptoms. A comprehensive review published in Frontiers in Human Neuroscience examined three neuromodulation approaches: repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), and deep brain stimulation (DBS), comparing their effectiveness, safety, and practical feasibility for patients with treatment-resistant auditory hallucinations (TR-AH) .

Why Do Auditory Hallucinations Resist Standard Treatment?

Auditory hallucinations affect 60 to 80% of individuals diagnosed with schizophrenia at some point during their illness, making them one of the most clinically significant and personally distressing symptoms in psychiatry. Patients describe hearing accusatory, commanding, or derogatory voices—sometimes whispered, sometimes shouted—that intrude during work, family time, or moments of rest. These voices feel utterly real, even though no external sound source exists .

First- and second-generation antipsychotic medications form the foundation of treatment, but they fail to eliminate hallucinations in a substantial portion of cases. When standard medications don't work, patients experience significant functional impairment, reduced quality of life, and increased financial burden. This treatment gap has sparked intense research into neuromodulation techniques—methods that use electrical or magnetic stimulation to directly target the brain regions generating these symptoms .

What Brain Areas Drive Auditory Hallucinations?

Over the past two decades, neuroimaging research has identified the specific brain regions involved in generating auditory hallucinations. The left temporoparietal junction (TPJ)—particularly the posterior superior temporal gyrus and supramarginal gyrus—emerges as a critical source. Additionally, hyperactivity appears in the inferior frontal gyrus and language areas. Crucially, auditory hallucinations involve a failure of top-down inhibitory control from frontal regions, particularly the dorsolateral prefrontal cortex and anterior cingulate cortex .

Brain imaging shows heightened metabolic activity and blood flow in hallucinating brains compared to resting or healthy brains. Electroencephalography (EEG) reveals aberrant gamma-band oscillations—abnormal electrical patterns—in patients experiencing hallucinations. This "misattribution" model suggests that internally generated speech is not properly tagged as self-generated due to deficient frontal inhibition, leading to the false perception of external auditory input. Neurochemically, dopamine dysregulation and problems with NMDA-receptor function contribute to this hyperexcitability, creating compelling targets for brain stimulation interventions .

How Do These Three Brain Stimulation Methods Work?

Repetitive Transcranial Magnetic Stimulation (rTMS): Uses magnetic coils placed on the scalp to generate electrical currents in targeted brain regions, typically applied to the left temporoparietal junction or prefrontal cortex to reduce hallucination-generating activity or enhance inhibitory control.
Transcranial Direct Current Stimulation (tDCS): Applies weak electrical currents through electrodes on the scalp to modulate brain activity, offering a non-invasive approach that can be administered in outpatient settings with minimal equipment.
Deep Brain Stimulation (DBS): Involves surgical implantation of electrodes directly into targeted brain regions, allowing precise, continuous stimulation of neural circuits involved in hallucination generation, though it carries surgical risks and requires ongoing monitoring.

Each method targets the same dysfunctional neural circuits but differs in invasiveness, precision, and practical feasibility. The choice between them depends on balancing effectiveness against safety concerns and real-world applicability .

What Does the Evidence Show About Effectiveness and Safety?

The research review synthesized findings from both successful and null randomized controlled trials—the gold standard for medical evidence—to provide a balanced assessment. Researchers carefully noted placebo effects and methodological differences across studies, recognizing that varying treatment outcomes reflect both genuine biological effects and study design variations .

A critical gap in current research is the lack of coherent reporting of patient-level characteristics, such as past medical history and comorbidities. This inconsistency hampers the ability to identify which patients respond best to which treatments. The review synthesizes safety and tolerability data across all three methods and evaluates how protocol differences might explain varying results. An emerging strategy involves imaging-guided targeting—using brain scans to personalize treatment by identifying each patient's specific neural abnormalities before selecting a stimulation approach .

What Should Patients and Clinicians Consider When Choosing a Treatment?

Invasiveness Level: rTMS and tDCS are non-invasive, requiring only scalp electrode placement, while DBS requires brain surgery and ongoing device management, making it suitable only for severe, refractory cases.
Treatment Setting: rTMS and tDCS can be administered in outpatient clinics, allowing patients to continue daily life, whereas DBS requires hospitalization for implantation and regular follow-up appointments for device adjustments.
Safety Profile: rTMS and tDCS carry minimal serious adverse effects, though some patients report headaches or scalp discomfort, while DBS carries surgical risks including infection, bleeding, and device malfunction requiring replacement.
Evidence Quality: The review consolidates findings from randomized controlled trials to help clinicians understand which methods have the strongest evidence base for specific patient populations.

The ultimate goal of this comprehensive evidence synthesis is to inform evidence-based clinical decision-making and guide research investment in neuromodulation approaches. By comparing the strengths and weaknesses of all three treatments, researchers aim to help clinicians select the most appropriate intervention for individual patients based on their specific clinical presentation, preferences, and circumstances .

For the millions of people living with treatment-resistant auditory hallucinations, these brain stimulation techniques represent a meaningful alternative when medications alone fall short. As research continues to refine protocols and identify which patients benefit most from each approach, personalized neuromodulation may become an increasingly important tool in psychiatric and neurological care.